Table 1.
Drugs that can cause ocular toxicity.1
Oral drugs | Use | Possible ocular side effects |
---|---|---|
Topiramate | Treatment of epilepsy | Secondary angle-closure glaucoma, visual field defects, oculogyric crisis, uveitis |
Gabapentin | Treatment of epilepsy | Nystagmus, diplopia and visual field defects |
Vigabatrin | Treatment of epilepsy | Visual field constriction, optic nerve atrophy |
Bisphosphonates (e.g., alendronate sodium,, risedronate, zoledronic acid | Treatment and prevetion of osteoporosis | Inflammation in the eye leads to conjunctivitis, episcleritis, scleritis, keratitis or uveitis, or corneal and scleral melting |
Chloroquine-based drugs (chloroquine, hydroxychloroquine | Treatment of malaria | Maculopathy, peripheral retinopathy |
Corticosteroids (e.g., prednisolone, dexamethasone) | Anti-inflammatory | Corticosteroid-induced raised intraocular pressure can lead to glaucoma, acceleration of cataract progression, and subcapsular cataracts. |
Ethambutol | Treatment of tuberculosis | Optic neuropathy characterised by bilateral central visual loss, decreased colour vision, central visual field defects, and (eventually) optic atrophy |
Fingolimod | Treatment of multiple sclerosis | Macular oedema, blurred vision, distortion, and impaired reading vision |
Isotretinoin and vitamin A | Acne and vitamin A deficiency treatment, respectively | Blepharoconjunctivitis, chalazia, corneal opacities, dry eyes, retinopathy |
Mitogen-activated protein kinase kinase enzyme (MEK) inhibitors, e.g., crizotinib | Treatment of advanced non-small cell lung cancer | Decreased visual acuity, visual field defects, dry eye symptoms, eyelid abnormalities, retinal vein occlusion, and retinopathy |
Pentosan polysulfate | Relief of bladder pain and discomfort related to interstitial cystitis | Maculopathy, retinal pigment epithelial lesions |
Phenothiazines | Treatment of schizophrenia and other psychotic disorders | Abnormal pigmentation of the eyelids, conjunctiva and cornea. Corneal epithelial changes (high dose). Corneal oedema (rare). |
Phosphodiesterase type 5 inhibitors, e.g., sildenafil, tadalafil | Treatment of erectile dysfunction | Persistent blurred vision, non-arteritic ischaemic optic neuropathy, cilioretinal artery occlusion, or central serous chorioretinopathy. |
Tamoxifen | Treatment of breast cancer | Intraretinal crystalline deposits, macular oedema, and punctate retinal pigmentary changes. |
Tetracyclines, e.g., doxycycline, tetracycline | Antibiotics | Nausea, vomiting, and morning headaches may be symptoms of idiopathic intracranial hypertension which can lead to permanent loss of vision |
Thiazolidinediones, e.g., glitazones, pioglitazone, rosiglitazone | Management of type 2 diabetes mellitus | Macular oedema |